ScinoPharm Taiwan Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2,851	4,166	3,942	4,295	4,081	4,055
Cash & Short-Term Investments	2,851	4,166	3,942	4,295	4,081	4,055
Cash Growth	-28.30%	5.70%	-8.22%	5.24%	0.64%	16.61%
Accounts Receivable	456.21	633.62	788.22	635.26	360.25	386.51
Other Receivables	22.5	20.57	25.23	18.28	32.8	86.43
Receivables	478.71	654.19	813.45	653.55	393.04	472.93
Inventory	1,904	1,673	1,512	1,189	1,345	1,246
Prepaid Expenses	178.5	114.91	105.79	132.24	96.85	108.08
Other Current Assets	-	-	8.3	51.13	50.71	34.31
Total Current Assets	5,412	6,608	6,381	6,320	5,967	5,916
Property, Plant & Equipment	4,100	4,426	4,399	4,498	4,648	4,841
Long-Term Investments	1,952	70.13	69.97	112.62	185.8	308.12
Other Intangible Assets	16.76	17.13	19.15	9.95	8.79	8.9
Long-Term Deferred Tax Assets	649.23	625.26	640.93	637.44	614.98	602.98
Other Long-Term Assets	181.64	196.6	211.48	332.96	267.07	170
Total Assets	12,312	11,943	11,722	11,911	11,691	11,847
Accounts Payable	112.02	82.17	102.46	126.5	70.86	160.84
Accrued Expenses	106.55	143.45	139.78	139.6	124.62	125.97
Short-Term Debt	139.48	35.56	32.14	77.6	-	9.49
Current Portion of Leases	23.8	19.64	17.56	17.89	16.17	16.5
Current Income Taxes Payable	21.63	11.5	62.6	99.64	71.17	67.97
Current Unearned Revenue	75.94	119.4	110.97	67.75	70.57	66.85
Other Current Liabilities	210.21	355.97	263.96	274.12	202.93	239.02
Total Current Liabilities	689.62	767.68	729.45	803.09	556.31	686.65
Long-Term Leases	612.63	620.34	570.23	581.18	540.27	550.18
Pension & Post-Retirement Benefits	11.44	23.61	54.51	74.49	79.55	79.23
Long-Term Deferred Tax Liabilities	1.63	1.3	1.66	-	0.35	-
Other Long-Term Liabilities	3.7	3.99	1.3	2.36	3.65	1.3
Total Liabilities	1,319	1,417	1,357	1,461	1,180	1,317
Common Stock	7,907	7,907	7,907	7,907	7,907	7,907
Additional Paid-In Capital	1,295	1,295	1,295	1,295	1,295	1,295
Retained Earnings	1,269	1,450	1,348	1,346	1,370	1,360
Comprehensive Income & Other	522.05	-126.18	-185.86	-98.18	-61.13	-33.04
Shareholders' Equity	10,993	10,526	10,364	10,450	10,511	10,529
Total Liabilities & Equity	12,312	11,943	11,722	11,911	11,691	11,847
Total Debt	775.9	675.54	619.92	676.67	556.43	576.18
Net Cash (Debt)	2,075	3,490	3,322	3,618	3,524	3,479
Net Cash Growth	-37.12%	5.08%	-8.19%	2.65%	1.31%	31.91%
Net Cash Per Share	2.62	4.40	4.19	4.56	4.45	4.39
Filing Date Shares Outstanding	790.74	790.74	790.74	790.74	790.74	790.74
Total Common Shares Outstanding	790.74	790.74	790.74	790.74	790.74	790.74
Working Capital	4,723	5,840	5,651	5,517	5,410	5,229
Book Value Per Share	13.90	13.31	13.11	13.22	13.29	13.32
Tangible Book Value	10,976	10,509	10,345	10,440	10,502	10,521
Tangible Book Value Per Share	13.88	13.29	13.08	13.20	13.28	13.30
Buildings	4,263	4,309	4,249	4,095	3,546	3,518
Machinery	6,757	6,647	6,432	6,249	5,641	5,598
Construction In Progress	58.6	194.04	77.72	155.62	1,119	1,052

Source: S&P Global Market Intelligence. Standard template. Financial Sources.